SCHEMBL27693282

SCHEMBL27693282

CC(F)C(C)(NC(=O)c1ccc2ccccc2c1O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.49
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
P2RX1 P51575 1/20 0.47
P2RX3 P56373 1/20 0.47
P2RX4 Q99571 1/20 0.47
P2RX7 Q99572 1/20 0.47
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
KDM4A O75164 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27693283 0.90 LDHA (0.51) LDHAPSEN1PSEN2APH1BNCSTN
SCHEMBL485239 0.81 KDM4E (0.63) LDHAP2RX1P2RX3P2RX4P2RX7
SCHEMBL10719823 0.81 LDHA (0.59) LDHAP2RX1P2RX3P2RX4P2RX7
SCHEMBL27693288 0.81 CXCR2 (0.54) LDHAPSEN1PSEN2APH1BNCSTN
SCHEMBL486080 0.80 KMT2A (0.47) LDHAPSEN1PSEN2APH1BNCSTN
SCHEMBL27693316 0.76 CXCR2 (0.44) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL27693310 0.74 CYP1A1 (0.55) LDHAPSEN1PSEN2APH1BNCSTN
SCHEMBL484914 0.74 KMT2A (0.51) LDHAP2RX1P2RX3P2RX4P2RX7
SCHEMBL27693304 0.72 KDM4E (0.52) MEN1KMT2AKDM4EMAPTHTT
SCHEMBL27693281 0.72 LDHA (0.49) LDHAPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN disclosed